About Intellectual Property IP Training IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars World IP Day WIPO Magazine Raising Awareness Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Enforcement Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid eMadrid Reference Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO ALERT Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight

WIPO Virtual Workshop on The Determinants of COVID-19 Vaccine Development Success

This virtual workshop, organized by the World Intellectual Property Organization (WIPO) on May 5, 2022, will present the Study The Determinants of COVID-19 Vaccine Development Success, by Ms. Rena M. Conti, Associate Professor in the Department of Markets, Public Policy and Law and Co-director of the Technology Policy and Research Institute at the Boston University Questrom School of Business. Ms. Conti looked at a number of select case studies and found that vaccine success or failure result from a variety of determinants that work together. The study highlights particularly the importance of research and manufacturing collaboration, political will, funding, among many other factors. The study was designed to provide academic insights in order to stimulate thinking and incentivize further discussion.

The peer reviewers, Ms. Shanelle Hall, former Assistant Secretary General at UNICEF/UN and founder of “The Yellow House” consultancy firm, and Mr. Axel Metzger, Professor of Civil Law and Intellectual Property at Humboldt-University in Berlin, will comment the study. The workshop will then move to a panel discussion with further contributions from Mr. Carsten Fink, Chief Economist at WIPO, Mr. Martin Friede, Unit Head, Product and Delivery Research, Immunization, Vaccines and Biologicals Department at the World Health Organization (WHO) and Ms. Deborah King, Vaccine Research Lead, Vaccines Priority Area at the Wellcome Trust. The workshop will serve as a forum for exchange of views and will conclude with an open discussion session among all panelists and an opportunity for questions from the audience.

The workshop is open to the interested public. The workshop wasbe held in virtual format and in English only.

Meeting codeWIPO/GC/COVID-19/GE/22
Date and venueMay 5, 2022 (Geneva, Switzerland) Onsite
Related linksWIPO Virtual Workshop examines “The Determinants of COVID-19 Vaccine Development Success” study during its launch: English
Topic(s)Workshops and Seminars

Meeting documents

WIPO/GC/COVID-19/GE/22/1 PROV.EnglishProvisional AgendaProvisional Agenda, Complete document (pdf)

Other related documents

WIPO/GC/COVID-19/GE/22/P1EnglishPresentation – Prof. Rena ContiPresentation – Prof. Rena Conti, Complete document (pdf)
WIPO/GC/COVID-19/GE/22/P2EnglishPresentation – Ms. Shanelle HallPresentation – Ms. Shanelle Hall, Complete document (pdf)
WIPO/GC/COVID-19/GE/22/P3EnglishPresentation – Prof. Axel MetzgerPresentation – Prof. Axel Metzger, Complete document (pdf)
WIPO/GC/COVID-19/GE/22/P5EnglishPresentation – Mr. Martin FriedePresentation – Mr. Martin Friede, Complete document (pdf)
WIPO/GC/COVID-19/GE/22/P6EnglishPresentation – Ms. Deborah King (PDF)
See also: Covid-19 vaccines report from the Wellcome Trust (HTML)
Presentation – Ms. Deborah King (PDF)<br>See also: Covid-19 vaccines report from the Wellcome Trust (HTML), Complete document (htm) Presentation – Ms. Deborah King (PDF)<br>See also: Covid-19 vaccines report from the Wellcome Trust (HTML), Complete document (pdf)
WIPO/GC/COVID-19/GE/22/WWW/572491EnglishStudy by Rena Conti and comments by Shanelle Hall and Axel Metzger - The Determinants of COVID-19 Vaccine Development SuccessStudy by Rena Conti and comments by Shanelle Hall and Axel Metzger - The Determinants of COVID-19 Vaccine Development Success, Complete document (pdf)